Keyphrases
Down Syndrome
100%
Keratoconus
100%
Gonadotropins
100%
Cognitive Dysfunction
18%
Comorbidity
18%
Comorbid
18%
Serum Amyloid A
18%
Tears
9%
Etiology
9%
Potential Biomarkers
9%
Eotaxin
9%
Support Vector Machine Analysis
9%
Plasma Proteins
9%
Interleukin-18 (IL-18)
9%
Cornea
9%
Prediction Accuracy
9%
Adiponectin
9%
Path Analysis
9%
Intercellular Adhesion molecule-1 (ICAM-1)
9%
I-309
9%
Ocular Comorbidities
9%
Vascular Cell Adhesion molecule-1 (VCAM-1)
9%
Fshr
9%
Operator Analysis
9%
Chromosomal Disorders
9%
Least Absolute Shrinkage and Selection Operator (LASSO)
9%
Gonadotropin-releasing Hormone Receptor (GnRHR)
9%
IL-6/IL-10
9%
Triplication
9%
Gonadotropin-releasing Hormone
9%
Degenerative Disease
9%
Comorbid Conditions
9%
Clinical Trials
9%
Adults with Down Syndrome
9%
Biofluids
9%
Interleukin-5 (IL-5)
9%
Screening Tool
9%
Electrochemiluminescence
9%
Prolactin-inducible Protein
9%
Chromosome 21
9%
Inflammatory Biomarkers
9%
Interleukin-7 (IL-7)
9%
Healthy Controls
9%
Pharmacology, Toxicology and Pharmaceutical Science
Keratoconus
100%
Down Syndrome
100%
Gonadotropin
100%
Biological Marker
36%
Comorbidity
27%
Cognitive Defect
18%
Amyloid Protein
18%
Diseases
18%
Interleukin 18
9%
Eotaxin 3
9%
Interleukin 10
9%
Prolactin
9%
Plasma Protein
9%
Degenerative Disease
9%
Polypyrrole
9%
Interleukin 5
9%
Clinical Trial
9%
Thymus and Activation Regulated Chemokine
9%
Gonadorelin
9%
Chromosome Disorder
9%
Adiponectin
9%
Tumor Necrosis Factor
9%
Inflammation
9%
Interleukin 7
9%
Interleukin 6
9%
Biochemistry, Genetics and Molecular Biology
Down Syndrome
100%
Gonadotropin
100%
Comorbidity
30%
Serum Amyloid A1
20%
Clinical Trial
10%
Eotaxin
10%
Interleukin 6
10%
Adiponectin
10%
Blood Plasma
10%
Interleukin 10
10%
Interleukin 5
10%
Tumor Necrosis Factor
10%
Interleukin 18
10%
Support Vector Machine
10%
Chromosomal Disorder
10%
Interleukin 7
10%
Gonadotropin-Releasing Hormone
10%
Chromosome 21
10%
Serum Total Protein
10%
Electrochemiluminescence
10%
Prolactin-Induced Protein
10%
GNRHR
10%